RRM2 regulates the high expression of PD-L1 via the ERK signaling pathway to play a cancer-promoting role in cervical cancer
Pathology - Research and Practice · 2025-08 · 272 · 156114
DOI: 10.1016/j.prp.2025.156114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025-08. Verfasst von Xieyidai Abuduhailili und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, China. Electronic address: 2508815542@qq.com. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Ribonucleoside Diphosphate Reductase, B7-H1 Antigen, MAP Kinase Signaling System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Xinjiang Uygur Autonomous Region Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Cervical cancer is one of the most common malignant tumors in women. Ribonucleotide reductase M2 (RRM2) plays a key role in tumor occurrence and progression. This study aimed to investigate the role of RRM2 in cervical cancer and its potential mechanism. METHODS: Ribonucleotide reductase M2 expression and its association with immune cell infiltration were assessed using bioinformatics analysis. Functional enrichment analysis of RRM2 and its coexpressed genes was performed. Furthermore, correlations between RRM2 and ERK1/2 and PD-L1 expressions were analyzed. In vitro and in vivo experiments, including quantitative real-time PCR, western blotting, flow cytometry, the Cell Counting Kit-8 assay, the TUNEL assay, and hematoxylin-eosin staining, were conducted to analyze the effects of RRM2 on ERK1/2 and PD-L1 expression and the malignant phenotype of cervical cells. RESULTS: Ribonucleotide reductase M2 was highly expressed in cervical cancer tissues compared with adjacent normal tissues and was negatively associated with immune cell infiltration and overall survival. Its knockdown suppressed proliferation, migration, and invasion and increased apoptosis. Mechanistically, RRM2 may promote cervical cancer development by upregulating ERK1/2 and PD-L1 progression in vitro and in vivo. CONCLUSION: Ribonucleotide reductase M2 promotes cervical cancer progression and positively regulates PD-L1 expression through the ERK signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, China. Electronic address: 2508815542@qq.com.
- Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, China. Electronic address: paopao1987123@163.com.
- Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, China.
- Department of Clinical Laboratory, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China. Electronic address: 18040823473@163.com.
Förderung
- Xinjiang Uygur Autonomous Region Natural Science Foundation
Zitieren
APA
Abuduhailili, X., Feng, Y., Lu, R., Li, Y., & Wang, S. (2025). RRM2 regulates the high expression of PD-L1 via the ERK signaling pathway to play a cancer-promoting role in cervical cancer. Pathology - Research and Practice, 272, 156114. https://doi.org/10.1016/j.prp.2025.156114
Vancouver
Abuduhailili X, Feng Y, Lu R, Li Y, Wang S. RRM2 regulates the high expression of PD-L1 via the ERK signaling pathway to play a cancer-promoting role in cervical cancer. Pathology - Research and Practice. 2025;272:156114. doi:10.1016/j.prp.2025.156114
BibTeX
@article{Abuduhailili2025,
author = {Abuduhailili, Xieyidai and Feng, Yangchun and Lu, Ruijiao and Li, Yuxia and Wang, Senyu},
title = {RRM2 regulates the high expression of PD-L1 via the ERK signaling pathway to play a cancer-promoting role in cervical cancer},
journal = {Pathology - Research and Practice},
year = {2025},
volume = {272},
pages = {156114},
doi = {10.1016/j.prp.2025.156114}
}
EUVIMED